(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

TrueCare Biomedix TCBINF022AE - 92" GRAVITY ADMIN SET W/ 0.2 MICRON GVS SPEEDFLOW INLINE FILTER, 1 Y-SITE, UNIV SPIKE, 20-DROP FILTERED (15 MICRON) DRIP, ROLL CLAMP, MALE L/L GRAVITY ADMIN SET, 50/CS

TrueCare Biomedix # TCBINF022AE - 92
Part Number TrueCare Biomedix TCBINF022AE
SKU Number CIA7002170
Sell Unit CASE
Ships Within Special Order
List Price $181.51
Enter a valid quantity
Product Description

TrueCare Biomedix TCBINF022AE - 92" GRAVITY ADMIN SET W/ 0.2 MICRON GVS SPEEDFLOW INLINE FILTER, 1 Y-SITE, UNIV SPIKE, 20-DROP FILTERED (15 MICRON) DRIP, ROLL CLAMP, MALE L/L GRAVITY ADMIN SET, 50/CS

IV Administration Set with GVS Speedfow 0.2 Micron Filter

Our IV Administration Set with a 0.2 Micron Filter consists of a universal spike, male swivel luer lock, roller clamp, drip chamber with a 15 micron filter, and a .02 micron in line filter. Each set is individually blister-packaged in quantities of 50 per box and features patient information directly on the exterior of the package.

Features

  • 20 drops/ml
  • One (1) Y-injection site 6 from distal end
  • Male swivel luer lock connector
  • Universal vented/non-vented spike
  • Roller clamp
  • 15 micron filter located in drip chamber for added protection
  • 0.2 micron GVS Speedflow in line Filter
  • 92" length
  • DEHP-free
  • Latex-free

Device Characteristics

  • What MRI safety information does the labeling contain? Labeling does not contain MRI Safety Information
  • Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437): No
  • Device labeled as "Not made with natural rubber latex": No
  • For Single-Use: Yes
  • Prescription Use (Rx): No
  • Over the Counter (OTC): No
  • Kit: No
  • Combination Product: No
  • Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P): No

Sterilization

  • Device Packaged as Sterile: Yes.
  • Requires Sterilization Prior to Use: No.

Roller clamp

Roller clamp equipped with a small roller that may be rolled counterclockwise to close off primary IV tubing or clockwise to open it. The roller clamp may also be manipulated to increase and decrease the flow of the IVsolution and is easily moved with the thumb, thus making it a one-handed convenience in the administration of IV therapy.

Why Universal Spike?

A vented/non-vented or "universal" spike allows an administration set to be used with all types of solution containers. The vent should be open when infusing from non-collapsible containers (glass and semi-rigid plastic) and closed when infusing from collapsible plastic containers (bags).

GVS Speedflow 0.2 Micron Filter

Membrane filtration

Filtration through a membrane means that the filter material will stop particles larger than the pore size rating. This enables an absolute pore size rating for the membranes for which they are clearly classified. Bacterial retention claims can be made based on the pore size of the membrane.

Pore size and challenge organism

  • 0.2 micron => Brevundimonas diminuta

Flow Rate 0.2 Micron Filter

Flow rate comparison for TPN solution through 0.2 micron IV filters.

High flow rate, longer life time!

Thanks to the special design of our housing and the structure of our HI-FLO PES membrane, Speedflow IV filters have high flow rates, which relates to longer product life before plugging. Under most circumstances, Speedflow will maintain flow without degradation over 120 hours of administration.

DEHP Free

Our IV sets are DEHP free. Infusion Therapy Standards of Practice advise to usee administration sets free of di-ethylhexyl-phthalate (DEHP) to administer lipid-based infusates, such as IVFE or TNA. DEHP is lipophilic and is extracted into the lipid solution with commonly used polyvinyl chloride administration sets and containers. DEHP is considered a toxin, and studies have demonstrated increased DEHP levels in lipid solutions, which is especially a risk with neonatal, pediatric, and long-term home care patients (42).

Related Products